Skip to main content
. 2020 May 5;142(27):11734–11742. doi: 10.1021/jacs.9b13907

Figure 4.

Figure 4

Degradation of BTK in patient-derived CLL cells. Patient-derived primary CLL cells were treated with BTK PROTACs for 18 h, followed by measuring BTK levels via Western blot. M-IGHV/UM-IGHV: mutated/unmutated immunoglobulin heavy chain variable region (IGHV) gene.